Clostridium difficile-associated diarrhea in adults.
Clostridium difficile is the most important cause of nosocomial diarrhea in adults. Illness may range from mild watery diarrhea to life-threatening colitis. An antecedent disruption of the normal colonic flora followed by exposure to a toxigenic strain of C. difficile are necessary first steps in the pathogenesis of disease. Diagnosis is based primarily on the detection of C. difficile toxin A or toxin B. First-line treatment is with oral metronidazole therapy. Treatment with oral vancomycin therapy should be reserved for patients who have contraindications or intolerance to metronidazole or who fail to respond to first-line therapy.
Poutanen
Susan M
SM
Department of Microbiology, Toronto Medical Laboratories and Mount Sinai Hospital.
Simor
Andrew E
AE
D000890:Anti-Infective Agents / Q000627:therapeutic use; D015373:Bacterial Typing Techniques; D002170:Canada / Q000453:epidemiology; D002353:Carrier State / Q000382:microbiology; D016360:Clostridioides difficile / Q000302:isolation & purification / Q000472:pathogenicity; D003015:Clostridium Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D003967:Diarrhea / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology* / Q000503:physiopathology; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
D000890:Anti-Infective Agents; D008795:Metronidazole